Switzerland
· Delayed Price · Currency is CHF Galderma Group AG Statistics
Total Valuation
Galderma Group AG has a market cap or net worth of CHF 23.04 billion. The enterprise value is 25.35 billion.
| Market Cap | 23.04B |
| Enterprise Value | 25.35B |
Important Dates
The next estimated earnings date is Thursday, March 6, 2025.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Galderma Group AG has 237.57 million shares outstanding. The number of shares has increased by 9.65% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 237.57M |
| Shares Change (YoY) | +9.65% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.23% |
| Owned by Institutions (%) | 13.89% |
| Float | 50.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 42.31 |
| PS Ratio | 142.22 |
| PB Ratio | 3.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 86.32 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.47, with an EV/FCF ratio of 94.94.
| EV / Earnings | -1,986.36 |
| EV / Sales | 6.53 |
| EV / EBITDA | 32.47 |
| EV / EBIT | 45.00 |
| EV / FCF | 94.94 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.39.
| Current Ratio | 1.20 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 3.39 |
| Debt / FCF | 9.92 |
| Interest Coverage | 1.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 592,774 |
| Profits Per Employee | -1,950 |
| Employee Count | 6,545 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 85.72 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 79.61 |
| Average Volume (20 Days) | 496,812 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Galderma Group AG had revenue of CHF 3.88 billion and -12.76 million in losses. Loss per share was -0.00.
| Revenue | 3.88B |
| Gross Profit | 2.70B |
| Operating Income | 563.24M |
| Pretax Income | 94.26M |
| Net Income | -12.76M |
| EBITDA | 756.53M |
| EBIT | 563.24M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 345.96 million in cash and 2.65 billion in debt, giving a net cash position of -2.30 billion or -9.69 per share.
| Cash & Cash Equivalents | 345.96M |
| Total Debt | 2.65B |
| Net Cash | -2.30B |
| Net Cash Per Share | -9.69 |
| Equity (Book Value) | 6.86B |
| Book Value Per Share | 28.87 |
| Working Capital | 265.09M |
Cash Flow
In the last 12 months, operating cash flow was 376.87 million and capital expenditures -109.90 million, giving a free cash flow of 266.97 million.
| Operating Cash Flow | 376.87M |
| Capital Expenditures | -109.90M |
| Free Cash Flow | 266.97M |
| FCF Per Share | 1.12 |
Margins
Gross margin is 69.54%, with operating and profit margins of 14.52% and -0.33%.
| Gross Margin | 69.54% |
| Operating Margin | 14.52% |
| Pretax Margin | 2.43% |
| Profit Margin | -0.33% |
| EBITDA Margin | 19.50% |
| EBIT Margin | 14.52% |
| FCF Margin | 6.88% |
Dividends & Yields
Galderma Group AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.65% |
| Shareholder Yield | -9.65% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Galderma Group AG has an Altman Z-Score of 3.76.
| Altman Z-Score | 3.76 |
| Piotroski F-Score | n/a |